Back to search

Article

The prognostic value of CD39+CD8+ T cells as a potential surrogate marker of tumor-specific T cells in Asian triple-negative breast cancer

2023-09-11

Abstract excerpt

Triple-negative breast cancer (TNBC) is a highly aggressive breast cancer subtype that is generally associated with poor prognosis in affected patients. Unfortunately, recently approved immune checkpoint inhibitors are efficacious in only a subset of patients. A surrogate marker for tumor-specific CD8 + T cells is urgently required to clarify the mechanisms of antitumor immune responses and help prognosticate TNBC...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
8f6b1790-a276-504c-846a-8b6cbaa4385e
DOI
10.21203/rs.3.rs-3336490/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
The prognostic value of CD39+CD8+ T cells as a potential surrogate marker of tumor-specific T cells in Asian triple-negative breast cancerDOI 10.21203/rs.3.rs-3336490/v1
Select a neighboring publication to make it the new centre.